Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors – an EBMT registry study by the Transplant Complications Working Party

Piekarska A, Abouqateb M, Boreland W, Peczynski C, Zaucha JM, Kroger N, Zeiser R, Ciceri F, Schroeder T, Luft T, Passweg J, Kunadt D, Stelljes M, Blau IW, Platzbecker U, Yakoub-Agha I, Blaise D, Raiola AM, Tischer J, Wagner-Drouet EM, Winkler J, Schmid C, Wulf G, Edinger M, Maertens J et al. Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors – an EBMT registry study by the Transplant Complications Working Party. Bone Marrow Transplant. 2025 Sep 11. doi:10.1038/s41409-025-02692-1. PMID: 40931084